A CLINICAL TRIAL TWO COMPARE TO TREATMENT SCHEDULES OF CONCURRENT CHEMORADIATION IN LOCALLY ADVANCED CANCER OF CERVIX.
Phase 3
- Registration Number
- CTRI/2010/091/000194
- Lead Sponsor
- DR.ARAVINDH.S.ANAND
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. women with biopsy proved uterine cancer, less than or equal to 70 yeras of age, locally advancer uerine cancer, WHO P.S 0-1, Normal CBC, LFT, RFT.
Exclusion Criteria
PRIOR CHEMOTHERAPY OR RADIATION, PARA AORTIC LYPH NODE INVOLVEMENT, DISTANT METASTASIS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Clinical response& local control of disease, disease free survival.<br>2. Delayed toxicityTimepoint: 3 years may extend to 5 years
- Secondary Outcome Measures
Name Time Method ACUTE TOXICITY & TOLERABILITYTimepoint: 1 YEAR